Guided Therapeutics Announces Filing of Application for NMPA Approval to Market and Sell LuViva in China

Guided Therapeutics’ Announces Data from Chinese NMPA Clinical Study Signed Off by All Four Clinical Sites with Better Than Expected Results

Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results